BMEZ Overview

BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, diversified financial services, health care technology, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.

Wall Street analysts forecast BMEZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BMEZ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

BlackRock Health Sciences Term Trust revenue for the last quarter amounts to NaN USD, decreased

BlackRock Health Sciences Term Trust. EPS for the last quarter amounts to USD, decreased

BlackRock Health Sciences Term Trust (BMEZ) has 0 emplpoyees as of June 15 2026.

Today BMEZ has the market capitalization of 0.00 USD.